BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 1911545)

  • 1. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
    Kannagi M; Harada S; Maruyama I; Inoko H; Igarashi H; Kuwashima G; Sato S; Morita M; Kidokoro M; Sugimoto M
    Int Immunol; 1991 Aug; 3(8):761-7. PubMed ID: 1911545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
    Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
    J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
    J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
    Kannagi M; Matsushita S; Shida H; Harada S
    Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
    Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
    Utz U; Banks D; Jacobson S; Biddison WE
    J Virol; 1996 Feb; 70(2):843-51. PubMed ID: 8551623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells.
    Kannagi M; Matsushita S; Harada S
    Int J Cancer; 1993 Jun; 54(4):582-8. PubMed ID: 8514449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
    J Neurol Sci; 1991 Sep; 105(1):99-107. PubMed ID: 1795176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
    Kubota R; Soldan SS; Martin R; Jacobson S
    J Immunol; 2000 May; 164(10):5192-8. PubMed ID: 10799878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
    J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
    Ishizawa M; Ganbaatar U; Hasegawa A; Takatsuka N; Kondo N; Yoneda T; Katagiri K; Masuda T; Utsunomiya A; Kannagi M
    Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
    Elovaara I; Utz U; Smith S; Jacobson S
    J Neuroimmunol; 1995 Dec; 63(1):47-53. PubMed ID: 8557824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
    Greten TF; Slansky JE; Kubota R; Soldan SS; Jaffee EM; Leist TP; Pardoll DM; Jacobson S; Schneck JP
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7568-73. PubMed ID: 9636190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.